Global Market Comments November 24, 2023 Fiat Lux Featured Trade: (MY UPDATED PERSONAL ECONOMIC INDICATOR), (HMC), (NSANY), (GM), (F), (TSLA) (HERE IS YOUR TOP PERFORMING INVESTMENT FOR THE NEXT FIVE YEARS), (ITB), (PHM), (KBH), (DHI) (TESTIMONIAL)
Dear John, I want to thank you for the outstanding conference in Miami. The hotel and food were first class along with the very informative presentations. I felt that the information I learned will more than pay for the trip. Hope to see you in Incline Village. Thanks Rich Detroit, Michigan
“Instead of buying low and selling high, you’re buying high and crossing your fingers,” said Bill Gross, former head of the bond giant PIMCO.
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.
Mad Hedge Technology Letter November 22, 2023 Fiat Lux Featured Trade: (YEN COULD DRAG DOWN TECH STOCKS) (FXY), ($COMPQ), (WEWKQ), (SOFTBANK)
The Japanese yen has helped boost tech stocks ($COMPQ). Institutional money is borrowing Japanese yen (FXY) by the bucketful because Japanese interest rates have been anchored at 0% and betting big on tech stocks. The strategy has worked like clockwork and Japanese stocks have also felt the wind at its sails. What now? Lurking in
(A TRAILER TO MATCH YOUR ELECTRIC VEHICLE) November 22, 2023 Hello everyone. The $50 billion travel trailer industry is playing catch-up. As more Americans move to electric cars, the trailer industry must evolve because the towing runs down the battery quickly. The drag on battery power can make towing an RV long distances
Global Market Comments November 22, 2023 Fiat Lux Featured Trade: (TRADING THE KENNEDY ASSASSINATION)
Mad Hedge Biotech and Healthcare Letter November 21, 2023 Fiat Lux Featured Trade: (A PRESCRIPTION FOR CAUTION) (VTRS), (PFE), (JNJ), (LLY), (BMY), (TEVA), (ABBV), (CVS)
In the rollercoaster world of pharmaceutical stocks, 2023 has been like riding the Cyclone at Coney Island – thrilling for some, nauseating for others. Take Pfizer (PFE), for instance. It’s seen its stock take a nosedive by 43.4%. That’s the kind of drop that makes you check if your wallet’s still there. Then there’s Johnson